Fetal Distress Clinical Trial
Official title:
A Mixed Methods Study to Explore the Feasibility of a Novel Continuous Fetal Monitoring
NCT number | NCT03370822 |
Other study ID # | 201920 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 22, 2016 |
Est. completion date | December 31, 2017 |
Verified date | May 2018 |
Source | University of Manchester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A stillbirth describes when a baby dies after 24 weeks of pregnancy and before being born. In the UK there are roughly 9 stillbirths every day. Normally, before a stillbirth occurs changes such as a slower heart rate and reduced movement take place. Fetal monitoring attempts to detect these changes so that babies can be delivered before they become severely ill. If a baby could be monitored continuously then these changes could be detected earlier. However, current forms of fetal monitoring, such as ultrasound, cannot be used for long periods of time and do not significantly reduce stillbirth rates. The Monica AN24 device is a continuous monitor which records the baby's heart rhythm using sensors placed on the mother's abdomen. As this is a new device there is little evidence about how well it works. In this project women will be asked how they feel about the device after wearing it. Doctors and midwives will also be asked about their views of the device. The effect of the mother's movement and the age of the baby on how well the Monica AN24 can record the baby's heart rhythm will also be assessed.
Status | Completed |
Enrollment | 20 |
Est. completion date | December 31, 2017 |
Est. primary completion date | July 31, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Women with singleton pregnancies attending St. Mary's Hospital, Manchester for antenatal care - No abnormality identified on ultrasound scan of fetal biometry and umbilical and fetal Doppler indices - Gestational age >24 weeks - Able to give informed consent Exclusion Criteria: - Multiple pregnancies - Maternal age <18 years - Individuals who do cannot speak or do not understand fluent English - Individuals unable to give informed consent - Women in active labour |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Central Manchester University Hospitals NHS Foundation Trust | Manchester |
Lead Sponsor | Collaborator |
---|---|
University of Manchester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mother's experience of wearing device | Qualitative Interview conducted within 24 hours of wearing the AN24 device | Immediately following the period (usually 12-24 hours) of wearing MONICA AN24 device | |
Primary | Change in Maternal Anxiety (GAD-2) | Change in maternal anxiety as assessed by Generalised Anxiety Disorder 2 item (GAD-2) | Maternal completion of the GAD-2 questionnaire before wearing the MONICA AN24 device and immediately following the period of wearing the MONICA AN24 device. | |
Primary | Change in Maternal Anxiety (Pregnancy Specific Anxiety Score) | Change in maternal anxiety as assessed by Pregnancy Specific Anxiety Score | Maternal completion of the Pregnancy Specific Anxiety Score questionnaire before wearing the MONICA AN24 device and immediately following the period of wearing the MONICA AN24 device. | |
Primary | Maternal Anxiety (STAI) | Change in maternal anxiety as assessed by State Trait Anxiety Index. | Maternal completion of the STAI before wearing the MONICA AN24 device and immediately following the period of wearing the MONICA AN24 device. | |
Secondary | Recording quality - defined as the percentage of time the device recorded the fetal heart rate | The recording quality of the Monica AN24 device defined as the percentage of time the device recorded the fetal heart rate) with differing levels of maternal activity and differing gestational ages. | During the 12-24 hour recording period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02221440 -
Maternal Oxygen Administration for Fetal Distress
|
N/A | |
Completed |
NCT04325243 -
Sildenafil Citrate and Intrapartum Fetal Distress
|
Phase 4 | |
Completed |
NCT03095937 -
Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) Patients
|
||
Completed |
NCT00185887 -
Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
|
N/A | |
Completed |
NCT02862925 -
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
|
N/A | |
Recruiting |
NCT06186973 -
Fetal Assessment of the Myocardium and Evaluation of the Neonate
|
||
Recruiting |
NCT05681624 -
Maternal Oxygen Supplementation for Intrauterine Resuscitation
|
N/A | |
Completed |
NCT05946681 -
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
|
||
Completed |
NCT03536910 -
Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique
|
N/A | |
Completed |
NCT03156608 -
Novii External Fetal Monitoring Device
|
N/A | |
Recruiting |
NCT00246766 -
Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy
|
N/A | |
Recruiting |
NCT04043299 -
Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
|
Phase 3 | |
Not yet recruiting |
NCT03859037 -
Effect of Umbilical Cord Milking on Transition of Preterm Babies During Resuscitation
|
N/A | |
Terminated |
NCT05147584 -
Trans-abdominal Fetal Pulse Oximetry
|
N/A | |
Not yet recruiting |
NCT05727241 -
Three-dimensional Umbilical Cord Coiling Index
|
||
Terminated |
NCT04081584 -
Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering
|
||
Completed |
NCT03764696 -
Maternal Oxygen Administration for Fetal Distress II
|
N/A | |
Completed |
NCT01042262 -
Maternal Oxygen Use During Delivery and Cord Blood Superoxide Dismutase
|
N/A | |
Not yet recruiting |
NCT04548453 -
Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions
|
Early Phase 1 | |
Completed |
NCT03159234 -
Prediction of Fetal Lung Maturity
|
N/A |